Flores, Mary Jane P.
HRN: 27-33-70 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2025
CEFUROXIME 750MG (VIAL)
06/15/2025
06/22/2025
IV
750 Mg
Q8
Snake Bite
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: No Wrong Dose
Final appropriateness: Yes
Overall appropriateness: Yes